[First Cases of Multisystem Inflammatory Syndrome following SARS-CoV-2 infection in Adults in Germany]
Related Experiment Video
Updated: May 1, 2026

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
1DRK-Kliniken Berlin-Westend, Klinik für Innere Medizin, Schwerpunkt Kardiologie.
Introduction:
Multisystem Inflammatory Syndrome is a rare condition that affects multiple organs following SARS-CoV-2 infection. It was first observed in children, however few cases of adults with Multisystem Inflammatory Syndrome (MIS-A) were published in the US and the UK. We present two cases of Multisystem Inflammatory Syndrome in adults which occurred in Germany.
History:
#1: A 27-year-old male presented with fever (40 °C), right lower abdominal pain, diarrhea and peritonism. #2: A 21-year-old female presented with fever (40 °C) occipital headaches, neck stiffness, and somnolence.
Findings:
#1: Increased inflammation parameters and elevated Nt-proBNP were found. Abdominal CT showed signs of ileitis terminalis and colitis. Crohn's disease was excluded endoscopically. Echocardiography showed minor pericardial effusion. A SARS-CoV-2 antibody test was positive. #2: Increased inflammation parameters and an increased Nt-proBNP were found. Cranial CT showed pathology. Meningitis was excluded via lumbar puncture. Thoracic CT and abdominal ultrasound showed no signs of infection. Echocardiography showed reduced LVEF (50 %). A SARS-CoV-2 antibody test was positive.
Therapy And Course:
#1: Antibiotic therapy as well as oral prednisolone didn't improve the clinical course. High-dose vasopressor therapy was necessary. The clinical condition improved only after adding hydrocortisone therapy. #2 Despite antibiotic therapy the clinical condition deteriorated. Because of insufficient effect of hydrocortisone, high-dose immunoglobulins were administered. Consequently, symptoms improved and LVEF normalized.
Conclusions:
Multisystem Inflammatory Syndrome presents as a chameleon of symptoms. In the context of the ongoing SARS-CoV-2 pandemic, rising numbers of cases in adults can be expected. In patients with fever, increased inflammation parameters and lack of other explanations, Multisystem Inflammatory Syndrome must be considered. Due to the potential severity of clinical courses and possible cardiac involvement, a therapy with hydrocortisone, ASS and immunoglobulins should be considered early.
Insights
Multisystem Inflammatory Syndrome in adults (MIS-A) can present with diverse symptoms following SARS-CoV-2 infection. Early consideration of MIS-A, including hydrocortisone and immunoglobulins, is crucial for managing severe cases and potential cardiac involvement.
Area of Science:
- Infectious Diseases
- Cardiology
- Gastroenterology
Background:
- Multisystem Inflammatory Syndrome in adults (MIS-A) is a rare post-SARS-CoV-2 complication, with limited reported cases in the US and UK.
- This report details two adult MIS-A cases from Germany, highlighting geographical expansion and clinical diversity.
Observation:
- Case 1: A 27-year-old male presented with fever, abdominal pain, and peritonism.
- Case 2: A 21-year-old female presented with fever, headache, neck stiffness, and somnolence.
Findings:
- Both patients exhibited elevated inflammatory markers and positive SARS-CoV-2 antibodies.
- Case 1 showed ileitis and colitis; Case 2 presented with reduced left ventricular ejection fraction (LVEF) and cranial CT pathology.
Implications:
- MIS-A requires a high index of suspicion in febrile patients with elevated inflammation and no clear alternative diagnosis.
- Prompt treatment with corticosteroids and immunoglobulins may be vital for managing severe MIS-A, particularly to mitigate cardiac complications.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Staphylococcal Skin Infections
Acute Inflammation II: Local and Systemic Effects
Bacterial Meningitis I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions

